Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | August 2006

Dialysis Roundtable

A panel of interventional radiologists discusses the issues and controversies surrounding hemodialysis, and the use of catheters, fistulae, and grafts as access.

By Abigail Falk, MD; Ziv Haskal, MD; Matthew S. Johnson, MD; Gordon McLennan, MD; and Tom Vesely, MD

evt | Article | June 2019

AV Access Covered Stent Clinical Trials: A Comparative Review

A status overview of six major clinical trials evaluating the use of covered stents in AV access treatment.

By Bart Dolmatch, MD, FSIR, and Ziv Haskal, MD, FSIR, FAHA, FACR, FCIRSE

evt | Article | June 2020

Roundtable Discussion: AV Use of Covered Stents: Dos and Don’ts

Experts share their tips on when, how, or if to deploy covered stents in the setting of arteriovenous grafts and/or fistulas.

With Ziv Haskal, MD, FSIR, FAHA, FACR, FCIRSE; Theodore F. Saad, MD; Haimanot (Monnie) Wasse, MD, MPH, FASN, FASDIN

evt | Article | June 2018

Key Updates in AV Access Trials

A summary of the current status of AV access trials in 2018.

Advertisement

Advertisement

evt | News | October 31, 2010

Gore Launches Study of Early TIPS Therapy for Ascites Patients

November 1, 2010—W.

evt | News | April 10, 2026

BD’s Liverty TIPS Stent Graft Receives CE Mark Approval in Europe

April 10, 2026—BD (Becton, Dickinson and Company) announced European CE Mark approval for the Liverty transjugular intrahepatic portosystemic shunt (TIPS) stent graft.

evt | Article | June 2020

Maintaining Progress in Challenging Times

By Bart Dolmatch, MD, and Stephen E. Hohmann, MD, FACS

evt | Article | June 2019

The Future of Dialysis Access Is Now

By Bart Dolmatch, MD, FSIR, and Monnie Wasse, MD, MPH, FASN

evt | Article | April 2007

Meeting the Challenge

By Barry T. Katzen, MD, Chief Medical Editor

evt | Article | April 2007

An Interview with Ziv J. Haskal, MD

At the forefront of radiology research, Dr. Haskal discusses stent graft use in dialysis, embolotherapy by IRs, and why 2007 is the year of DVT.

By Ziv J. Haskal, MD

evt | Article | October 2020

A Decade at the Helm

An interview with Ziv J Haskal, MD, on his tenure as JVIR’s Editor-in-Chief.

evt | Article | June 2015

Stent Graft Use in AV Access Maintenance: What We've
Learned

Leading clinical researcher Ziv J. Haskal, MD, discusses ideal application, pitfall avoidance, and long-term results.

With Ziv J. Haskal, MD

evt | Article | June 2018

Challenging Cases in Dialysis Access

With Moderators: Bart L. Dolmatch, MD, FSIR; and Saravanan Balamuthusamy, MD, FASN, FASDIN; and Panel: Saravanan Balamuthusamy, MD, FASN, FASDIN; Ziv J. Haskal, MD, FSIR, FAHA, FACR, FCIRSE; and Stephen E. Hohmann, MD, FACS

Sponsored by Gore & Associates

evt | Article | June 2018 Supplement

Stent Grafts: An Important Tool in Today's Dialysis Treatment Algorithm

Two dialysis experts discuss their approach to access challenges.

With John R. Ross, MD, and Ziv J. Haskal, MD, FSIR, FAHA, FACR

evt | Article | April 2023

Key Papers in Embolotherapy

An overview of significant embolotherapy articles published in 2022 and summaries of the potential impact each may have on the field.

By Tiago Bilhim, MD, PhD, EBIR-ES, FCIRSE, FSIR, and Ziv J. Haskal, MD, FSIR, FAHA, FACR, FCIRSE

evt | Article | June 2016

Ask the Experts: What Is the Biggest Data Deficit in Dialysis Access Intervention? What Is the Solution?

With Abigail Falk, MD, FSIR, FASDIN; Ziv J. Haskal, MD, FSIR, FAHA, FACR; Alexander S. Yevzlin, MD, FASN; Christopher Owens, MD, MSc; Ted Saad, MD; and Lee Kirksey, MD, MBA

Sponsored by Penumbra, Inc.

evt | Article | May 2015

Indigo® Mechanical Thrombectomy System for Thromboembolic Disease

Experts within the endovascular community share their experiences with and perspectives on clot management protocols and the risks and benefits of the various available treatment options.

With Ziv J. Haskal, MD, FSIR, FAHA, FACR; Nicholas Hendricks, MD; Rahul S. Patel, MD; George L. Adams, MD, MHS; Vinayak Subramanian, BS; James F. Benenati, MD; Frank R. Arko III, MD; Richard R. Saxon, MD, FSIR; and Mahmood K. Razavi, MD, FSIR

evt | News | February 9, 2010

Bard's Flair Stent Graft Bests Balloon Angioplasty in Study

February 10, 2010—Bard Peripheral Vascular, Inc. (Tempe, AZ) announced that Ziv J. Haskal, MD, et al published trial results in the New England Journal of Medicine (NEJM) showing that the Bard Flair endovascular stent graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone (2010;362:494–503). The Flair device has been approved by the US Food and Drug Administration for use in treating stenoses at the venous anastomosis of expanded polytetrafluoroethylene or other synthetic arteriovenous access grafts. In an accompanying editorial in NEJM, “Fistula First, Stent Graft Second,” Robert K. Kerlan, Jr, MD, and Jeanne M. LaBerge, MD, further discuss the Flair investigators' findings and their implications (2010;362:550–552).

evt | News | February 9, 2010

Bard’s Flair Stent Graft Demonstrates Superiority to Balloon Angioplasty for Failing Dialysis Grafts

February 10, 2010—Bard Peripheral Vascular, Inc. (Tempe, AZ) announced that Ziv J. Haskal, MD, et al published trial results in the New England Journal of Medicine (NEJM) showing that the Bard Flair endovascular stent graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone (2010;362:494–503). The Flair device has been approved by the US Food and Drug Administration for use in treating stenoses at the venous anastomosis of expanded polytetrafluoroethylene or other synthetic arteriovenous access grafts. In an accompanying editorial in NEJM, "Fistula First, Stent Graft Second," Robert K. Kerlan, Jr, MD, and Jeanne M. LaBerge, MD, further discuss the Flair investigators’ findings and their implications (2010;362:550–552).

evt | News | July 6, 2016

Two-Year RENOVA Results Compare Stent Graft Versus PTA to Treat Arteriovenous Graft Anastomotic Stenosis

July 7, 2016—The final 2-year results of the RENOVA study were published by Ziv J. Haskal, MD, et al online ahead of print in the Journal of Vascular and Interventional Radiology (JVIR).


1
2

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button